纤溶酶原激活物抑制剂1(SERPINE1)基因多态性与动脉瘤性蛛网膜下腔出血的关联
该前瞻性队列研究于2012至2015年在2家主要学术机构纳入动脉瘤性蛛网膜下腔出血(aSAH)患者,采用Taqman基因分型检测6个SERPINE1单核苷酸多态性,分析其与临床结局的关联。多变量分析显示,rs2227631的AA基因型合并4G/4G基因型与迟发性脑缺血风险增加相关,rs7242的GG基因型合并rs2227684的AA基因型与不良功能结局风险降低相关。作者认为这些关联可能源于纤溶酶原激活物抑制剂1水平的改变。
要点
- rs2227631的AA基因型与4G/4G基因型存在关联,rs7242的GG基因型与rs2227684的AA基因型存在关联。
- 多变量分析中,rs2227631 AA基因型合并4G/4G基因型患者发生迟发性脑缺血的风险增加。
- rs7242 GG基因型合并rs2227684 AA基因型患者不良功能结局的风险降低。
核心结论
- SERPINE1基因多态性与aSAH后的迟发性脑缺血和功能结局相关。
- 这些关联可能源于纤溶酶原激活物抑制剂1水平的改变。
研究设计与样本
- 2012年至2015年,aSAH患者被前瞻性纳入CARAS(脑动脉瘤肾素血管紧张素系统)研究,该研究在2家主要学术机构开展。
- 采用5'外切核酸酶(Taqman)基因分型法检测6个常见的SERPINE1单核苷酸多态性。
主要发现
- rs2227631的AA基因型与4G/4G基因型存在关联,rs7242的GG基因型与rs2227684的AA基因型存在关联。
- 多变量分析中,rs2227631 AA基因型合并4G/4G基因型患者发生迟发性脑缺血的风险增加。
- rs7242 GG基因型合并rs2227684 AA基因型患者不良功能结局的风险降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic variations of the serine proteinase inhibitor family E member 1 (SERPINE1) gene, which encodes plasminogen activator inhibitor 1, correlate with serum levels of its product and are associated with thrombophilia and coronary atherosclerosis. Various SERPINE1 ;gene polymorphisms have been identified. However, only the functional 5G/4G polymorphism has been assessed in the context of aneurysmal subarachnoid hemorrhage (aSAH). We assessed associations of 6 SERPINE1 polymorphisms with the clinical sequelae of aSAH. METHODS: From 2012 to 2015, patients with aSAH were prospectively enrolled into the CARAS (Cerebral Aneurysm Renin Angiotensin System) study at 2 major academic institutions. Blood samples were used to evaluate 6 common SERPINE1 single nucleotide polymorphisms via 5' exonuclease (Taqman) genotyping assays. RESULTS: There was an association of the AA genotype of rs2227631 with the 4G/4G genotype and of the GG genotype of rs7242 with the AA genotype of rs2227684. In multivariable analysis, patients with the AA genotype of rs2227631 and 4G/4G genotype had an increased risk for developing delayed cerebral ischemia. Patients with the GG genotype of rs7242 and AA genotype of rs2227684 had a decreased risk for a poor functional outcome. CONCLUSIONS: SERPINE1 gene polymorphisms were associated with delayed cerebral ischemia and functional outcome after aSAH. These associations may arise from alterations of plasminogen activator inhibitor 1 levels.
引用
- Hendrix P, Foreman PM, Harrigan MR, et al. Association of Plasminogen Activator Inhibitor 1 (SERPINE1) Polymorphisms and Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2017. PMID: 28599907. doi:10.1016/j.wneu.2017.05.175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。